- Obniżka
Indeks: 56391
Crash Course Endocrinology: Updated Print + digital version Edition
Autor: Daniel Horton-Szar
Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów
Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów
Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów
Opis
Table of Contents
1. CHEMOTHERAPY AGENTS –WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS
a. Cytotoxic
b. Targeted Agents
c. Hormonal Agents
d. Immunotherapy
2. RADIATION THERAPY
3. MOST COMMON HEME QUESTIONS
a. Anemia
b. Thrombocytopenia
c. Thrombosis
d. Transfusion reactions
4. SCREENING
a. Breast cancer
b. Cervical
c. Colon Cancer
d. Prostate
e. Lung Cancer
5. BREAST CANCER
a. Non-invasive
b. Invasive
c. Inflammatory breast cancer
d. Phyllodes
e. Pagets
6. HEAD AND NECK
7. THYROID CARCINOMAS
8. GI CANCER
a. Esophagus
b. Gastric/GEJ
c. Colon
d. Rectal
e. Anus
f. Pancreas
g. Cholangiocarcinoma
h. Hepatocellular Carcinoma
i. Neuroendocrine tumors
9. GU CANCER
a. Bladder
b. Kidney
c. Prostate
d. Testicular
10. GYNECOLOGICAL MALIGNANCIES
a. Cervical
b. Endometrial
c. Ovarian
d. Uterine
11. MELANOMAS
12. THORACIC
a. Small cell lung cancer
b. Non-small cell lung cancer
13. SARCOMAS
14. OCCULT PRIMARY
15. BASICS OF PATHOLOGY AND HEMATOLOGY
a. Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.
b. Solid tumor pathology basics
16. BASICS OF BONE MARROW TRANSPLANTATION
a. Types (Allo, Auto)
b. Indications
17. LYMPHOMAS
a. Hodgkins Lymphoma
i. Classical HL
ii. Nodular lymphocyte-predominant HL
b. Non-Hodgkins Lymphoma
i. B-cell NHL
a) Diffuse large B-cell Lymphoma (DLBCL)
b) Follicular Lymphoma
c) Mantle Cell Lymphoma (MCL)
d) Small Lymphocytic Lymphoma (SLL)
e) Primary CNS Lymphoma
f) Primary Mediastinal Lymphoma (PML)
g) Burkitt Lymphoma (BL)
h) Primary Effusion Lymphoma
i) Double-hit Lymphoma
j) Primary Effusion Lymphoma (PEL)
ii. T-Cell NHL
a) Peripheral T-cell Lymphoma (PTCL)
b) Primary Cutaneous T-cell Lymphoma
c) Anaplastic Large Cell Lymphoma (ALCL)
d) Post-Transplant Lymphoproliferative
18. LEUKEMIAS
a) Acute Leukemias
i. Acute Myeloid Leukemia (AML)
ii. APL
i. Acute Lymphoblastic Leukemia (ALL)
b) Chronic Leukemias:
i. Chronic Myeloid Leukemia (CML)
ii. Chronic Lymphocytic Leukemia (CLL)
iii. Hairy Cell Leukemia
19. PLASMA CELL DISORDERS:
a. Monoclonal Gammopathy of Undetermined Significance (MGUS)
b. Multiple Myeloma (MM)
c. Lymphoplasmacyctic Lymphoma (including Waldenstroms Macroglobulinemia)
d. Solitary Plasmacytoma
e. AL Amyloidosis
f. POEMS Syndrome
20. MYELOPROLIFERATIVE NEOPLASMS
a. Polycythemia Vera (PV)
b. Essential Thrombocythemia (ET)
c. Primary Myelofibrosis (PMF)
d. Systemic Mastocytosis (SM)
21. MYELODYSPLASTIC SYNDROMES
22. GUIDELINES FOR SUPPORTIVE CARE
a. Management of Side Effects of Chemotherapy
i. Myelosuppression
ii. Nausea
iii. Vomiting
iv. Diarrhea
v. Mucositis
vi. Anorexia, weight loss
b. Management of Cancer-related pain
c. Management of Cachexia
23. ONCOLOGIC EMERGENCIES
a. Neutropenic Fever
b. Spinal Cord Compression
c. Tumor Lysis Syndrome
d. Superior vena cava syndrome
e. Hypercalcemia of malignancy
f. Hyperleukocytosis and leukostasis
24. GENETIC AND FAMILIAL ASSESSMENT FOR FAMILIAL CANCER SYNDROMES
25. END OF LIFE
Indeks: 56391
Autor: Daniel Horton-Szar
Indeks: 56392
Autor: Daniel Horton-Szar
Indeks: 56393
Autor: Daniel Dr Horton-Szar
Indeks: 77951
Autor: Fong Nigel Jie Ming
Indeks: 80406
Autor: Sotirios A. Tsementzis